Charlotte Ferrell
Psychiatric/Mental Health · Williston, NDNPI 1841490554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Alkermes, Inc. at 54.2% of the total. Reporting peaked in 2022 at $199 and has fallen 90.5% since, to $19 in 2025.
Across 30 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$272
- AbbVie$96
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
- Otsuka America Pharmaceutical, Inc.$33
- Teva Pharmaceuticals USA, Inc.$21
- E.r. Squibb & Sons, L.L.C.$19
- plus $14 from 1 others
What the payments were for
- Food & beverage$48496%
- Education$194%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 16 | $272 |
| AbbVie | 6 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$503 in reported general payments places this provider in the 65th percentile of 92 psychiatric/mental health providers in North Dakota.
See all psychiatric/mental health providers in North Dakota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 44 | $137,270 |
| AristadaAripiprazole Lauroxil | 39 | $119,881 |
| VraylarCariprazine Hcl | 23 | $29,078 |
| LybalviOlanzapine/Samidorphan Malate | 16 | $25,375 |
| RexultiBrexpiprazole | 13 | $19,183 |
| Vilazodone Hcl | 53 | $4,479 |
| Aripiprazole | 40 | $1,439 |
| Oxcarbazepine | 35 | $1,238 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 27 | $1,229 |
| Clozapine | 25 | $936 |
| Risperidone | 60 | $739 |
| Duloxetine Hcl | 31 | $693 |
| Haloperidol | 56 | $659 |
| Prazosin Hcl | 42 | $601 |
| Divalproex Sodium | 69 | $598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alkermes, Inc.Aristada, Lybalvi | $272 | $145,25655 claims |
| AbbVieVraylar | $96 | $29,07823 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $33 | $19,18313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 92 psychiatric/mental health providers in North Dakota.
Other psychiatric/mental health in Williston
- Brittany BollingerWilliston$933
- McKenzie MoorWilliston$903
- Elizabeth BootsWilliston$567
- Jessica Graham SteinhauerFargo$8K
- Madison KirschBismarck$3K
- Roxann BrownMinot$3K
- Rebecca KussJamestown$3K
- Tonya AndersonMinot$3K
- Jennifer WoiwodeMinot$2K
- Linda VolnessFargo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.